Is imidafenacin an alternative to current antimuscarinic drugs for patients with overactive bladder syndrome?
ConclusionsIn conclusion, imidafenacin was comparable to other ADs in the treatment of OAB. Moreover, imidafenacin presented a lower dry mouth rate, lower constipation rate and higher adherence and persistence.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research
More News: Constipation | Databases & Libraries | Incontinence | OBGYN | Overactive Bladder | Overactive Bladder Syndrome | Statistics | Study